Followers | 507 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, April 14, 2015 11:27:49 AM
bullish
macd crossup
## source: finance.yahoo.com
Mon, 13 Apr 2015 22:00:19 GMT ~ Most active Nasdaq-traded stocks
read full: http://sg.finance.yahoo.com/news/most-active-nasdaq-traded-stocks-172145872--finance.html
*********************************************************
Mon, 13 Apr 2015 22:00:18 GMT ~ Nasdaq stocks posting largest percentage decreases
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************
Tue, 07 Apr 2015 13:20:21 GMT ~ ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015
[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Apr. 7, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and ...
read full: http://www.noodls.com/view/AE668A8962512D17F0AE9DE3E7E5868890029E58
*********************************************************
Tue, 07 Apr 2015 13:00:00 GMT ~ ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015
[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 14th Annual Needham Healthcare Conference on Tuesday, April 14, 2015, at 9:20 a.m.
read full: http://finance.yahoo.com/news/acadia-pharmaceuticals-present-14th-annual-130000315.html
*********************************************************
Mon, 06 Apr 2015 23:58:00 GMT ~ SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit – ACAD
[GlobeNewswire] - STEVENSON, Md., April 6, 2015-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ...
read full: http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-235800141.html
*********************************************************
$ACAD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ACAD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ACAD/company-info
Ticker: $ACAD
OTC Market Place: Not Available
CIK code: 0001070494
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
Incorporated In: DE, USA
$ACAD share structure
## source: otcmarkets.com
Market Value: $3,752,432,594 a/o Apr 13, 2015
Shares Outstanding: 100,171,719 a/o Jan 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
$ACAD extra dd links
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ACAD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ACAD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ACAD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/news - http://finance.yahoo.com/q/h?s=ACAD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ACAD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ACAD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ACAD
DTCC (dtcc.com): http://search2.dtcc.com/?q=ACADIA+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ACADIA+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ACADIA+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.acadia-pharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.acadia-pharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.acadia-pharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ACAD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001070494&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ACAD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ACAD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ACAD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ACAD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ACAD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ACAD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ACAD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ACAD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ACAD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ACAD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ACAD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ACAD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ACAD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ACAD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ACAD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ACAD
$ACAD DD Notes ~ http://www.ddnotesmaker.com/ACAD
Recent ACAD News
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/17/2024 08:05:00 PM
- Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome • Business Wire • 05/15/2024 01:05:00 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 05/09/2024 08:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:10:16 PM
- Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview • Business Wire • 05/08/2024 08:05:00 PM
- Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship • Business Wire • 04/29/2024 08:16:00 PM
- Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024 • Business Wire • 04/24/2024 08:05:00 PM
- Acadia Pharmaceuticals annonce que la présentation de drogue nouvelle pour la trofinetide dans le traitement du syndrome de Rett a été acceptée pour dépôt et évaluation prioritaire par Santé Canada • Business Wire • 04/22/2024 01:04:00 PM
- Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada • Business Wire • 04/22/2024 01:04:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/19/2024 08:05:00 PM
- Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting • Business Wire • 04/17/2024 08:05:00 PM
- Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development • Business Wire • 04/02/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/01/2024 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/15/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day • Business Wire • 03/13/2024 08:05:00 PM
- Oracle Soars 13% With Exceptional Growth and Boosts Nvidia Shares With Collaboration Announcement, and More • IH Market News • 03/12/2024 11:21:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:05:55 PM
- Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia • Business Wire • 03/11/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024 • Business Wire • 02/29/2024 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:13:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:10:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:02:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:16:24 PM
- Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview • Business Wire • 02/27/2024 09:05:00 PM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM